Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease

Neuroscience Letters

Volumn 333, Issue 1, 2002, Pages 9-12

  Mubumbila, Victor ^a   Sutter, Anne ^a   Ptok, Ursula ^b   Heun, Reinhard ^b   Quirin Stricker, Christiane ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer's disease; Choline acetyltransferase; Polymorphism

Indexed keywords

ALANINE; CHOLINE ACETYLTRANSFERASE; GLYCINE; RNA; THREONINE;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA TRANSLATION;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; CHI-SQUARE DISTRIBUTION; CHOLINE O-ACETYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0037110992     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00955-2     Document Type: Article

References (21)

1. Amouyel P., Richard F., Cottel D., Amant C., Codron V., Helbecque N. The deletion allele of the angiotensin 1 converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett. 217:1996;203-205.
2. Beach T.G., Kuo Y.M., Spiegel K., Emmerling M.R., Sue L., Kokjohn K., Roher A.E. The cholinergic deficit coincides with A beta deposition at the earliest histopathologic stages of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 59:2000;4308-4313.
3. Boissière F., Faucneux B., Agid Y., Hirsch E.C. Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease. Neurosci. Lett. 225:1997;169-172.
4. Dournoud P., Delaere P., Hauw J.J., Epelbaum J. Differential correlation between neurochemical deficits, neuropathology and cognitive status in Alzheimer's disease. Neurobiol. Aging. 16:1995;817-823.
5. Goate A.M., Chartier-Harlin M.C., Mullan M.C., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M.A., Roses A.D., Williamson R., Rossor M.N., Owen M.J., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimers's disease. Nature. 349:1991;704-706.
6. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
7. Haroutunia V., Greig N., Pei X.F., Utsuki T., Glick R., Acevedo L.D., Davis K.L., Walace W.C. Pharmacological modulation of Alzheimer's beta amyloid precursor protein levels in the CNS of rats with forebrain cholinergic system lesions. Mol. Brain Res. 46:1997;161-168.
8. Kehoe P., Russ C., Mcllory S., Williams H., Holmans P., Holmes C., Liolitsa D., Vahidassr D., Powell J., McGleenon B., Liddell M., Plomin R., Dynan K., Williams N., Neal J., Cairns N.J., Wilcock G., Passmore P., Lovestone S., Williams J., Owen M. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer's disease. Nat. Genet. 21:1999;71-72.
9. Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides, in positions +5 and +6. EMBO J. 16:1997;2482-2492.
10. Levy-Lehad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., Crowley A.C., Fu Y.H., Guenette S.Y., Galas D., Nemens E., Wijsman E.M., Bird T.D., Schelenberg G.D., Tanzi R.E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
11. Lin L., Georgievska B., Mattsson A., Isacson O. Cognitive changes and modified processing amyloid precursor protein in the cortical and, hippocampal system after cholinergic synapse loss and muscarinic receptor activation. Proc. Natl. Acad. Sci. USA. 96:1999;12108-12113.
12. Mesulam M.M. The systems-level organization of cholinergic innervation in the cerebral cortex and its alteration in Alzheimer's disease. Prog. Brain Res. 109:1996;285-298.
13. Meziane H., Dodar J.C., Mathis C., Little S., Clemens J., Paul S.M., Ungerer A. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. USA. 95:1998;12683-12688.
14. Muir J.L. Acetylcholine, aging and Alzheimer's disease. Pharmacol. Biochem. Behav. 56:1997;687-696.
15. Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 258:1992;304-307.
16. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
17. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20:1992;1433.
18. Roses A.D. Alzheimer's disease: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases. Am. J. Hum. Genet. 81:1998;49-57.
19. Rossner S., Ueberham U., Yu J., Kirazov L., Schliebs R., Perezpolo J.R., Bigl V. In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity. Eur. J. Neurosci. 9:1997;2125-2134.
20. Sherrington K., Govaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikdea M., Chi H., Lin C., Li G., St.George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
21. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. 90:1993;1977-1981.